YU53803A - Peptidi i/ili proteini kao i njihova primena za pripremanje terapeutskih i/ili preventivnih lekova - Google Patents
Peptidi i/ili proteini kao i njihova primena za pripremanje terapeutskih i/ili preventivnih lekovaInfo
- Publication number
- YU53803A YU53803A YU53803A YUP53803A YU53803A YU 53803 A YU53803 A YU 53803A YU 53803 A YU53803 A YU 53803A YU P53803 A YUP53803 A YU P53803A YU 53803 A YU53803 A YU 53803A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- group
- peptides
- proteins
- therapeutic
- production
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 230000000069 prophylactic effect Effects 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000004475 Arginine Substances 0.000 abstract 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 229930195734 saturated hydrocarbon Natural products 0.000 abstract 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/363—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Pronalazak se odnosi na peptide ili proteine, opšte formule I (SEQ ID NO 1,2), u kojoj R1 i R2, isti ili različiti, označavaju vodonik, zasićen ili nezasićen ugljovodonični ostatak sa 1 do 3, a naročito do 10, atoma ugljenika, Z1 označava histidin- ili prolin-ostatak, Z2 označava arginin-ostatak, peptid-ostatak ili protein-ostatak, sa početnim arginin-ostatkom, naročito sa 2 do 30 amino kiselina, kao i njihove soli, a takodje npr. i amide, ili smeše supstanci jedne sa drugom i/ili bar sa jednom drugom supstancom, za terapeutsku i/ili preventivnu primenu u humanoj i/ili veterinarskoj medicini.[The invention relates to peptides or proteins of general formula (I), where R1 and R2 independently = hydrogen, a saturated or unsaturated hydrocarbon group with 1 to 3, in particular up to 10 carbon atoms, Z1 = a histidine or proline group, Z2 = an arginine group, a peptide group or protein group with arginine at the initial terminus, in particular with 2 to 30 amino acids and the salts thereof as well as, for example the amides thereof, or material mixtures thereof and/or with at least one further material. (I) can be used for therapeutic and/or prophylactic applications in human and/or veterinary medicine.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT20632000 | 2000-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
YU53803A true YU53803A (sh) | 2006-03-03 |
Family
ID=3689750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU53803A YU53803A (sh) | 2000-12-12 | 2001-12-07 | Peptidi i/ili proteini kao i njihova primena za pripremanje terapeutskih i/ili preventivnih lekova |
Country Status (31)
Country | Link |
---|---|
US (4) | US7271144B2 (sh) |
EP (2) | EP1341819B1 (sh) |
JP (1) | JP4181874B2 (sh) |
KR (1) | KR100864069B1 (sh) |
CN (2) | CN101676299A (sh) |
AT (2) | ATE329614T1 (sh) |
AU (1) | AU2002221316A1 (sh) |
BG (1) | BG107891A (sh) |
BR (1) | BR0116122A (sh) |
CA (1) | CA2430972C (sh) |
CY (2) | CY1106108T1 (sh) |
CZ (1) | CZ20031630A3 (sh) |
DE (2) | DE50110182D1 (sh) |
DK (2) | DK1341819T3 (sh) |
EA (1) | EA005576B1 (sh) |
EE (1) | EE200300283A (sh) |
ES (2) | ES2323963T3 (sh) |
HK (1) | HK1084400A1 (sh) |
HR (1) | HRP20030564A2 (sh) |
HU (1) | HUP0401536A3 (sh) |
IL (2) | IL156360A0 (sh) |
MX (1) | MXPA03005218A (sh) |
NO (1) | NO330767B1 (sh) |
NZ (1) | NZ550619A (sh) |
PL (2) | PL209419B1 (sh) |
PT (2) | PT1341819E (sh) |
SI (2) | SI1586586T1 (sh) |
SK (1) | SK7062003A3 (sh) |
WO (1) | WO2002048180A2 (sh) |
YU (1) | YU53803A (sh) |
ZA (1) | ZA200304545B (sh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002221316A1 (en) | 2000-12-12 | 2002-06-24 | Fibrex Medical Research & Development Gmbh | Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
BRPI0506148A (pt) * | 2004-06-25 | 2006-10-24 | Fibrex Medical Res & Dev Gmbh | preparação farmacêutica para o tratamento de choque |
FR2879604B1 (fr) * | 2004-12-22 | 2010-08-13 | Biomerieux Sa | Peptides citrullines derives de la fibrine reconnus par des auto-anticorps specifiques de la polyarthrite rhumatoide, et leurs utilisations |
AT502987A1 (de) | 2005-12-23 | 2007-07-15 | Fibrex Medical Res & Dev Gmbh | Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen |
WO2007095659A1 (de) * | 2006-02-23 | 2007-08-30 | Fibrex Medical Research & Development Gmbh | Peptide und peptid-derivate, herstellun derselben sowie deren verwendung zur herstellung eines therapeutisch und/oder präventiv wirkenden arzneimittels |
PT1987063E (pt) * | 2006-02-23 | 2009-12-15 | Fibrex Medical Res & Dev Gmbh | Péptidos e derivados peptídicos, a produção destes bem como a sua utilização para a preparação de uma composição farmacêutica terapeuticamente e/ou preventivamente activa |
CA2641908A1 (en) * | 2006-02-23 | 2007-08-30 | Fibrex Medical Research & Development Gmbh | Peptides and peptide derivatives as well as pharmaceutical compositions containing the same |
FR2900657B1 (fr) | 2006-05-03 | 2009-04-17 | Univ Toulouse | Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide |
WO2009038729A2 (en) | 2007-09-17 | 2009-03-26 | Regenerx Biopharmaceuticals, Inc. | Compositions and methods utilizing fibrin beta chain fragments of the bbeta chain of fibrinogen |
FR2908134B1 (fr) * | 2007-12-04 | 2012-10-12 | Univ Toulouse 3 Paul Sabatier | Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide |
WO2009096502A1 (ja) * | 2008-01-31 | 2009-08-06 | Japan As Represented By President Of National Center Of Neurology And Psychiatry | うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断 |
US20090286725A1 (en) * | 2008-05-15 | 2009-11-19 | Fibrex Medical Research & Development Gmbh | Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
US8088890B2 (en) | 2008-09-26 | 2012-01-03 | Fibrex Medical Research & Development Gmbh | Peptides and peptidomimetic compounds, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
WO2010043444A2 (en) * | 2008-10-15 | 2010-04-22 | Fibrex Medical Research & Development Gmbh | Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof |
US20100152832A1 (en) * | 2008-12-12 | 2010-06-17 | Medtronic Vascular, Inc. | Apparatus and Methods for Treatment of Aneurysms With Fibrin Derived Peptide B-Beta |
US10531655B2 (en) | 2011-12-02 | 2020-01-14 | The Regents Of The University Of California | Reperfusion protection solution and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4927916A (en) | 1984-04-23 | 1990-05-22 | The General Hospital Corporation | Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides |
US5965107A (en) * | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
DE19729591A1 (de) * | 1997-07-10 | 1999-02-11 | Therasorb Medizinische Systeme | Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen |
FR2795735B1 (fr) * | 1999-07-01 | 2001-09-07 | Univ Toulouse | Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumatoide |
AU2002221316A1 (en) * | 2000-12-12 | 2002-06-24 | Fibrex Medical Research & Development Gmbh | Peptides and/or proteins and use thereof for the production of a therapeutic and/or prophylactic medicament |
US7201763B2 (en) | 2001-10-24 | 2007-04-10 | Boston Scientific Scimed, Inc. | Distal balloon waist material relief and method of manufacture |
-
2001
- 2001-12-07 AU AU2002221316A patent/AU2002221316A1/en not_active Abandoned
- 2001-12-07 WO PCT/AT2001/000387 patent/WO2002048180A2/de active IP Right Grant
- 2001-12-07 PT PT01270546T patent/PT1341819E/pt unknown
- 2001-12-07 BR BR0116122-9A patent/BR0116122A/pt not_active Application Discontinuation
- 2001-12-07 SK SK706-2003A patent/SK7062003A3/sk unknown
- 2001-12-07 PL PL362924A patent/PL209419B1/pl not_active IP Right Cessation
- 2001-12-07 CN CN200910163553A patent/CN101676299A/zh active Pending
- 2001-12-07 JP JP2002549711A patent/JP4181874B2/ja not_active Expired - Fee Related
- 2001-12-07 PT PT05012488T patent/PT1586586E/pt unknown
- 2001-12-07 NZ NZ550619A patent/NZ550619A/en unknown
- 2001-12-07 AT AT01270546T patent/ATE329614T1/de active
- 2001-12-07 DK DK01270546T patent/DK1341819T3/da active
- 2001-12-07 CN CN018225993A patent/CN1518558B/zh not_active Expired - Fee Related
- 2001-12-07 SI SI200130917T patent/SI1586586T1/sl unknown
- 2001-12-07 EP EP01270546A patent/EP1341819B1/de not_active Expired - Lifetime
- 2001-12-07 YU YU53803A patent/YU53803A/sh unknown
- 2001-12-07 IL IL15636001A patent/IL156360A0/xx unknown
- 2001-12-07 PL PL390342A patent/PL209752B1/pl not_active IP Right Cessation
- 2001-12-07 DK DK05012488T patent/DK1586586T3/da active
- 2001-12-07 CZ CZ20031630A patent/CZ20031630A3/cs unknown
- 2001-12-07 ES ES05012488T patent/ES2323963T3/es not_active Expired - Lifetime
- 2001-12-07 AT AT05012488T patent/ATE425184T1/de active
- 2001-12-07 HU HU0401536A patent/HUP0401536A3/hu unknown
- 2001-12-07 MX MXPA03005218A patent/MXPA03005218A/es active IP Right Grant
- 2001-12-07 EP EP05012488A patent/EP1586586B1/de not_active Expired - Lifetime
- 2001-12-07 KR KR1020037007799A patent/KR100864069B1/ko not_active IP Right Cessation
- 2001-12-07 DE DE50110182T patent/DE50110182D1/de not_active Expired - Lifetime
- 2001-12-07 EA EA200300678A patent/EA005576B1/ru not_active IP Right Cessation
- 2001-12-07 DE DE50114771T patent/DE50114771D1/de not_active Expired - Lifetime
- 2001-12-07 EE EEP200300283A patent/EE200300283A/xx unknown
- 2001-12-07 ES ES01270546T patent/ES2266093T3/es not_active Expired - Lifetime
- 2001-12-07 CA CA2430972A patent/CA2430972C/en not_active Expired - Fee Related
- 2001-12-07 SI SI200130609T patent/SI1341819T1/sl unknown
-
2003
- 2003-06-09 BG BG107891A patent/BG107891A/bg unknown
- 2003-06-09 IL IL156360A patent/IL156360A/en not_active IP Right Cessation
- 2003-06-11 US US10/459,030 patent/US7271144B2/en not_active Expired - Fee Related
- 2003-06-12 NO NO20032656A patent/NO330767B1/no not_active IP Right Cessation
- 2003-07-10 HR HR20030564A patent/HRP20030564A2/hr not_active Application Discontinuation
-
2004
- 2004-06-11 ZA ZA200304545A patent/ZA200304545B/en unknown
-
2006
- 2006-04-13 HK HK06104567.9A patent/HK1084400A1/xx not_active IP Right Cessation
- 2006-06-27 CY CY20061100876T patent/CY1106108T1/el unknown
- 2006-10-03 US US11/542,050 patent/US7494973B2/en not_active Expired - Lifetime
-
2007
- 2007-09-06 US US11/899,611 patent/US7811985B2/en not_active Expired - Fee Related
-
2008
- 2008-10-09 US US12/248,656 patent/US8067373B2/en not_active Expired - Fee Related
-
2009
- 2009-05-29 CY CY20091100574T patent/CY1109107T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU53803A (sh) | Peptidi i/ili proteini kao i njihova primena za pripremanje terapeutskih i/ili preventivnih lekova | |
ATE183514T1 (de) | Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten | |
WO2000012542A3 (en) | Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties | |
TW343198B (en) | Cyclopeptides useful as adhesion inhibitors, process for the preparation thereof, and pharmaceutical composition containing them | |
EA200000652A1 (ru) | Кристаллы глюкагоноподобного пептида 1 | |
BR0109494A (pt) | Produção de fatores recombinantes de coagulação do sangue em linhas celulares humanas | |
ATE494902T1 (de) | Ein huhn gnrh-ii analog zur verwendung in der reduktion des tumorzellwachstums | |
NZ592510A (en) | HLA-A*1101-restricted WTI peptide and pharmaceutical composition comprising the same | |
MX361694B (es) | Fragmentos de peptidos para inducir sintesis de proteinas de matriz extra-celular. | |
CA2370289A1 (en) | Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides | |
GB9108652D0 (en) | Immunoreactive compounds | |
MX9703642A (es) | Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana. | |
CY1109631T1 (el) | Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ | |
CY1111431T1 (el) | Μεταλλαγμενες πρωτεϊνες πλακουντιου αυξητικου παραγοντα τυπου 1, μεθοδος παρασκευης και εφαρμογες αυτων | |
AU8649101A (en) | Integrin binding motif containing peptides and methods of treating skeletal diseases | |
BR0009472A (pt) | Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas | |
ATE365542T1 (de) | Lyophilisierbare pharmazeutische plazebozusammensetzung , insbesondere auf basis von proteinen oder polypeptiden, zur nachahmung eines arzneimittels | |
CA2334941A1 (en) | Tnf-derived peptides for use in treating oedema | |
ATE3416T1 (de) | Pharmakologisch aktive peptide und diese enthaltende arzneimittel. | |
NZ591827A (en) | Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject | |
AR026068A1 (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia. | |
KR890014735A (ko) | 변형 단백질 | |
GB9604518D0 (en) | Novel compounds | |
DE69215537D1 (de) | t-PA SUBSTITUTIONSVARIANTEN MIT VERBESSERTER FIBRINSPEZIFITÄT | |
ES416516A1 (es) | Un procedimiento para la preparacion de nonapeptidos. |